美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

阿庫拉製藥

0.0100

+0.00951900.00%

成交量：120.00

成交額：1.20

市值：66.50萬

市盈率：-0.50

高：0.0100

開：0.0100

低：0.0100

收：0.0005

52周最高：0.0200

52周最低：0.0001

股本：6,649.93萬

流通股本：999.03萬

量比：1.54

換手率：0.00%

股息：- -

股息率：- -

每股收益(TTM):-0.0200

每股收益(LYR):-0.0200

淨資產收益率：15.24%

總資產收益率：-58.46%

市淨率：3.74

市盈率(LYR):-0.50

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

阿庫拉製藥

交易所：

EXPERT

成立時間：

1935

員工人數：

- -

公司地址：

616 N. North Court,Suite 120,Palatine,Illinois,United States

官網：

http://www.acurapharm.com

郵編：

60067

電話：

傳真：

847 705 5399

簡介：

Acura Pharmaceuticals, Inc.是一家紐約公司，其子公司是一家專業製藥公司，從事產品和技術的研究、開發和商業化，旨在解決藥物濫用和誤用。該公司已經研發了兩項專利技術。公司的反感技術（Aversion Technology）是將惰性成分的混合物用於藥片和膠囊，旨在解決一些常見的類鴉片藥物的濫用。 Pfizer控股公司的鹽酸羥考酮片是首個被批准銷售的利用反感技術製成的藥品，是公司與 Pfizer的子公司簽訂協議后合作開發的。該公司還開發了結合非活性成分的阻礙技術,防止從藥片中提取偽麻黃鹼，防止偽麻黃鹼直接轉換成冰毒。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ACUR/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"ACUR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUR\",,,,,undefined,":{"symbol":"ACUR","market":"US","secType":"STK","nameCN":"阿庫拉製藥","latestPrice":0.01,"timestamp":1773933572459,"preClose":0.0005,"halted":0,"volume":120,"delay":15,"changeRate":19,"floatShares":9990324,"shares":66499283,"eps":-0.02,"marketStatus":"交易中","change":0.0095,"latestTime":"03-19 11:19:32 EDT 延時","open":0.01,"high":0.01,"low":0.01,"amount":1.2,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.02,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1773950400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.0005,"volumeRatio":1.5415},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUR\",,,,,undefined,":{"symbol":"ACUR","floatShares":9990324,"roa":"-58.46%","roe":"15.24%","lyrEps":-0.02,"volumeRatio":1.5415,"shares":66499283,"dividePrice":0,"high":0.01,"amplitude":0,"preClose":0.0005,"low":0.01,"week52Low":0.0001,"pbRate":"3.74","psRate":"0.43","week52High":0.02,"institutionHeld":0,"latestPrice":0.01,"eps":-0.02,"divideRate":0,"volume":120,"delay":15,"ttmEps":-0.02,"open":0.01,"prevYearClose":0.0005,"prevWeekClose":0.0005,"prevMonthClose":0.0005,"prevQuarterClose":0.0005,"fiveDayClose":0.0005,"twentyDayClose":0.0005,"sixtyDayClose":0.0005},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACUR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-05-17","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1621224000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-03-31","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1617163200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-11-16","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1605502800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-06-29","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1593403200000,"reportTimeType":"post","actualEps":null},{"date":"2020-06-15","symbol":"ACUR","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1592251200000,"name":null,"time":"盤後","dateTimestamp":1592193600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACUR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACUR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":29262,"yearFounded":1935,"address":"616 N. North Court,Suite 120,Palatine,Illinois,United States","zipCode":"60067","officePhone":"847 705 7709","officeFax":"847 705 5399"},"stockCompanyDetail":{"websiteUrl":"http://www.acurapharm.com","stockEarnings":[{"period":"1week","weight":-0.1892},{"period":"1month","weight":0},{"period":"3month","weight":0.4925},{"period":"6month","weight":0.6575},{"period":"1year","weight":0.0345},{"period":"ytd","weight":1.611}],"description":"Acura Pharmaceuticals, Inc.是一家紐約公司，其子公司是一家專業製藥公司，從事產品和技術的研究、開發和商業化，旨在解決藥物濫用和誤用。該公司已經研發了兩項專利技術。公司的反感技術 （Aversion Technology） 是將惰性成分的混合物用於藥片和膠囊，旨在解決一些常見的類鴉片藥物的濫用。 Pfizer控股公司的鹽酸羥考酮片是首個被批准銷售的利用反感技術製成的藥品，是公司與 Pfizer的子公司簽訂協議后合作開發的。該公司還開發了結合非活性成分的阻礙技術,防止從藥片中提取偽麻黃鹼，防止偽麻黃鹼直接轉換成冰毒。","exchange":"EXPERT","name":"阿庫拉製藥","nameEN":"Acura Pharmaceuticals, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ACUR\",market:\"US\",,,undefined,":null}}